Picture loading failed.

Anti-NT5E therapeutic antibody (Pre-made Oleclumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Oleclumab (INN; development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic and colorectal and other cancers.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-394-1mg 1mg 3090
GMP-Bios-ab-394-10mg 10mg 21890
GMP-Bios-ab-394-100mg 100mg 148000
GMP-Bios-ab-394-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-NT5E therapeutic antibody (Pre-made Oleclumab biosimilar,Whole mAb)
INN Name Oleclumab
TargetNT5E
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCLambda
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2016
Year Recommended2017
CompaniesMedImmune;AstraZeneca;European Network of Gynaecological Oncological Trial Groups;Jules Bordet Institute
Conditions Approvedna
Conditions ActiveNon-small cell lung cancer;Ovarian cancer;Breast cancer;Pancreatic cancer;Bladder cancer;Solid tumours
Conditions Discontinuedna
Development Techna